Safety of drug-eluting stents

  title={Safety of drug-eluting stents},
  author={Stephan Windecker and Peter J{\"u}ni},
  journal={Nature Clinical Practice Cardiovascular Medicine},
Drug-eluting stents (DESs) effectively reduce angiographic restenosis and the clinical need for repeat revascularization procedures as compared with bare-metal stents. Widely publicized concerns arose recently about the incidence of late and very late stent thrombosis with the use of first-generation DESs. Recent systematic reviews and large-scale registry studies demonstrated similar rates of overall mortality and myocardial infarction for patients treated with either DESs or bare-metal stents… CONTINUE READING


Publications citing this paper.
Showing 1-9 of 9 extracted citations


Publications referenced by this paper.
Showing 1-10 of 74 references

American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association

  • CL Grines
  • American College of Physicians
  • 2007

Clinical endpoints in coronary stent trials : a case for standardized definitions

  • AA Bavry
  • Circulation
  • 2007

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting

  • J Daemen
  • 2007
3 Excerpts

Early and late coronary stent thrombosis of sirolimuseluting and paclitaxeleluting stents in routine clinical practice : data from a large twoinstitutional cohort study

  • MN Babapulle
  • Lancet
  • 2007

Effectiveness and safety of drug-eluting stents in Ontario

  • JV Tu
  • N Engl J Med
  • 2007

Effects of pretreatment with clopidogrel and aspirin followed by long - term therapy in patients undergoing percutaneous coronary intervention : the PCICURE study

  • EL Eisenstein
  • Lancet
  • 2007

Similar Papers

Loading similar papers…